We are aware that at Dr. Robert Getzenberg's request, the journal Urology on Oct. 3, 2011, retracted his manuscript entitled, «EPCA - 2: a highly
specific serum marker for prostate cancer.»
Take, for example, prostate -
specific antigen (PSA), which is a blood
serum marker used to test men for prostate cancer.